CaSR may reside both in the apical and basolateral membranes of DCT cells and effects of plasma- vs. urinary Ca2+ on NCC may be different, i.e., inhibition by hypercalcemia vs. stimulation in hypercalciuric conditions [5,13,56,89]. This evidence concerns the gene CASR and hypercalcemia disease.